On September 3, 2024, Edwards Lifesciences completed the sale of its Critical Care product group, a global leader in advanced patient monitoring solutions, to Becton, Dickinson and Company.
Cassels acted as Canadian counsel for Edwards Lifesciences.
Cassels
Canadian Corporate Law Firm
representative work
Edwards Lifesciences Completes Sale of Critical Care Business to Becton, Dickinson and Company
09/11/2024
__________
RELATED EXPERTISE: Private Equity | Mergers & Acquisitions | Employment & Labour | International Trade | Regulatory